US Stocks
/
Telomir Pharmaceuticals, Inc. Share Price

Telomir Pharmaceuticals, Inc. Share Price

NASDAQ: TELO | Micro Cap
$1.19
+$0.02 (1.28%) Last updated on 28 Aug, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Telomir Pharmaceuticals, Inc. Stock Performance

Open
$1.19
Prev. Close
$1.17
Circuit Range
N/A
Day Range
$1.19 - $1.19
Year Range
$0.90 - $2.09
Volume
227
Average Traded
$1.19

Telomir Pharmaceuticals, Inc. Share Price Today

As of 30 August 2026, Telomir Pharmaceuticals, Inc.'s share price is $1.19. The stock opened at $1.19, compared to its previous close of $1.17. During today's trading session, Telomir Pharmaceuticals, Inc.'s share price traded between $1.19 and $1.19, with an average price of $1.19. Over the past 52 weeks, the stock has recorded a high of $2.09 and a low of $0.90. In terms of performance, Telomir Pharmaceuticals, Inc.'s share price has declined by 10.23% over the last six months and is down 10.90% on a year-on-year basis.

Telomir Pharmaceuticals, Inc. Share Price Chart

$1.19$1.19
L
Show Current Price
H

Telomir Pharmaceuticals, Inc. Stock Fundamentals & Key Indicators

Market Cap
$37.51M
PE Ratio (TTM)
-3.59
Dividend Yield
N/A
EPS (TTM)
$-0.33
Revenue (TTM)
N/A
Return On Equity (TTM)
-176.10%
Profit Margin
N/A
Debt to Equity
0.24
Quarterly Earnings Growth YoY
81.60%

Telomir Pharmaceuticals, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsMar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025
RevenueN/AN/AN/AN/AN/AN/A
Net Profit-$6.25M-$1.45M-$5.99M-$2.18M-$5.07M-$1.10M
Net Profit MarginN/AN/AN/AN/AN/AN/A
Income ChangeN/A76.83%-313.44%63.61%-132.58%78.26%

Telomir Pharmaceuticals, Inc. Annual Profit & Loss

All figures in USD

Particulars202320242025
RevenueN/AN/AN/A
Net Profit-$13.07M-$16.53M-$10.41M
Net Profit MarginN/AN/AN/A
Income ChangeN/A-26.48%37.01%

About Telomir Pharmaceuticals, Inc.

Telomir Pharmaceuticals, Inc., a preclinical-stage biotechnology company, focuses on reversing biological aging and degenerative diseases. It is developing Telomir-1, an oral small molecule metal ion regulator designed to protect against age-related conditions, including Progeria, Wilson's disease, and age-related macular degeneration (amd), as well as type 2 diabetes, cancer, and Alzheimer's disease. The company was formerly known as Metallo Therapies Inc. and changed its name to Telomir Pharmaceuticals, Inc. in October 2022. Telomir Pharmaceuticals, Inc. was incorporated in 2021 and is headquartered in Miami, Florida.

Telomir Pharmaceuticals, Inc. Historical Returns

MonthOpenCloseChange %
Aug 2026
$1.22
$1.18
-3.28%
Jul 2026
$1.29
$1.22
-3.94%
Jun 2026
$1.24
$1.27
-1.93%
May 2026
$1.41
$1.29
-8.16%
Apr 2026
$1.25
$1.41
+10.16%
Mar 2026
$1.20
$1.28
-3.03%
Feb 2026
$1.17
$1.32
+14.78%
Jan 2026
$1.32
$1.15
-13.53%
Dec 2025
$1.31
$1.33
-0.75%
Nov 2025
$1.50
$1.34
-13.83%
Oct 2025
$1.39
$1.55
+11.87%
Sep 2025
$1.29
$1.39
+4.51%

TELO Share Price FAQs

What is Telomir Pharmaceuticals, Inc. share price today?

chevron-up
Telomir Pharmaceuticals, Inc. share price today is $1.19 as on August 28, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Telomir Pharmaceuticals, Inc. stock?

chevron-up
The 52 week high of Telomir Pharmaceuticals, Inc. stock is $2.09, while the 52 week low is $0.90 as of 28 Aug '26.

What is TELO's market capitalisation today?

chevron-up
TELO market capitalisation is $37.51M as of August 30, 2026, at 3:28 pm IST.

What is TELO's net income for the last quarter?

chevron-up
TELO's net income for the last quarter is -0.00B USD.

What is the 5 year returns of TELO?

chevron-up
The 5 year returns of TELO is -86.93% as on 28 Aug '26.

What is the high & low stock price of TELO today?

chevron-up
TELO stock price hit a high of $1.19 and low of $1.19 as of 28 Aug '26.

Can I buy TELO shares in India?

chevron-up
Yes. You can buy TELO in India by opening an international trading account.